氯胺酮治疗青少年抑郁症：一例报告 - Suppr

Suppr

超能文献

Ketamine as a Treatment for Adolescent Depression: A Case Report.

作者信息

Dwyer Jennifer B, Beyer Chad, Wilkinson Samuel T, Ostroff Robert B, Qayyum Zheala, Bloch Michael H

机构信息

Yale University, New Haven, CT.

Stellenbosch University, Stellenbosch, South Africa and Yale University.

出版信息

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):352-354. doi: 10.1016/j.jaac.2017.01.006.

DOI:10.1016/j.jaac.2017.01.006

PMID:28335880

Abstract

摘要

相似文献

Ketamine as a Treatment for Adolescent Depression: A Case Report.

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):352-354. doi: 10.1016/j.jaac.2017.01.006.

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.

Psychol Med. 2016 Feb;46(3):623-35. doi: 10.1017/S0033291715002159. Epub 2015 Oct 19.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

J Clin Psychiatry. 2016 Jun;77(6):e719-25. doi: 10.4088/JCP.15m10056.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.

Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.

Eur Neuropsychopharmacol. 2016 Jun;26(6):994-1003. doi: 10.1016/j.euroneuro.2016.03.006. Epub 2016 Apr 28.

Successful Use of Ketamine for the Treatment of Psychotic Depression in a Teenager.

J Child Adolesc Psychopharmacol. 2019 Aug;29(6):472-473. doi: 10.1089/cap.2019.0028. Epub 2019 Jun 4.

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.

Psychiatry Res. 2014 Feb 28;215(2):355-61. doi: 10.1016/j.psychres.2013.12.008. Epub 2013 Dec 13.

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856.

Serial infusions of low-dose ketamine for major depression.

J Psychopharmacol. 2013 May;27(5):444-50. doi: 10.1177/0269881113478283. Epub 2013 Feb 20.

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038.

引用本文的文献

Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review.

Eur Child Adolesc Psychiatry. 2025 Jan;34(1):141-157. doi: 10.1007/s00787-024-02458-y. Epub 2024 May 16.

Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression.

Pharmaceuticals (Basel). 2024 Mar 10;17(3):358. doi: 10.3390/ph17030358.

Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression.

J Child Adolesc Psychopharmacol. 2024 Mar;34(2):73-79. doi: 10.1089/cap.2023.0047. Epub 2024 Jan 3.

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial.

Child Adolesc Psychiatry Ment Health. 2023 Sep 14;17(1):108. doi: 10.1186/s13034-023-00647-2.

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression.

Gen Psychiatr. 2023 Jun 21;36(3):e101007. doi: 10.1136/gpsych-2023-101007. eCollection 2023.

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression.

Front Psychiatry. 2023 Jun 2;14:1118737. doi: 10.3389/fpsyt.2023.1118737. eCollection 2023.

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.

Front Psychiatry. 2023 Mar 30;14:1141988. doi: 10.3389/fpsyt.2023.1141988. eCollection 2023.

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression.

Brain Sci. 2023 Jan 13;13(1):142. doi: 10.3390/brainsci13010142.

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.

BMC Psychiatry. 2022 Nov 30;22(1):744. doi: 10.1186/s12888-022-04388-y.

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression.

Front Behav Neurosci. 2022 Jun 21;16:938044. doi: 10.3389/fnbeh.2022.938044. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Ketamine as a Treatment for Adolescent Depression: A Case Report.

作者信息

Dwyer Jennifer B, Beyer Chad, Wilkinson Samuel T, Ostroff Robert B, Qayyum Zheala, Bloch Michael H

机构信息

Yale University, New Haven, CT.

Stellenbosch University, Stellenbosch, South Africa and Yale University.

出版信息

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):352-354. doi: 10.1016/j.jaac.2017.01.006.

DOI:10.1016/j.jaac.2017.01.006

PMID:28335880

Abstract

摘要

相似文献

Ketamine as a Treatment for Adolescent Depression: A Case Report.

J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):352-354. doi: 10.1016/j.jaac.2017.01.006.

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.

Psychol Med. 2016 Feb;46(3):623-35. doi: 10.1017/S0033291715002159. Epub 2015 Oct 19.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

J Clin Psychiatry. 2016 Jun;77(6):e719-25. doi: 10.4088/JCP.15m10056.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.

Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.

Eur Neuropsychopharmacol. 2016 Jun;26(6):994-1003. doi: 10.1016/j.euroneuro.2016.03.006. Epub 2016 Apr 28.

Successful Use of Ketamine for the Treatment of Psychotic Depression in a Teenager.

J Child Adolesc Psychopharmacol. 2019 Aug;29(6):472-473. doi: 10.1089/cap.2019.0028. Epub 2019 Jun 4.

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.

Psychiatry Res. 2014 Feb 28;215(2):355-61. doi: 10.1016/j.psychres.2013.12.008. Epub 2013 Dec 13.

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856.

Serial infusions of low-dose ketamine for major depression.

J Psychopharmacol. 2013 May;27(5):444-50. doi: 10.1177/0269881113478283. Epub 2013 Feb 20.

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Biol Psychiatry. 2010 Jan 15;67(2):139-45. doi: 10.1016/j.biopsych.2009.08.038.

引用本文的文献

Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review.

Eur Child Adolesc Psychiatry. 2025 Jan;34(1):141-157. doi: 10.1007/s00787-024-02458-y. Epub 2024 May 16.

Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression.

Pharmaceuticals (Basel). 2024 Mar 10;17(3):358. doi: 10.3390/ph17030358.

Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression.

J Child Adolesc Psychopharmacol. 2024 Mar;34(2):73-79. doi: 10.1089/cap.2023.0047. Epub 2024 Jan 3.

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial.

Child Adolesc Psychiatry Ment Health. 2023 Sep 14;17(1):108. doi: 10.1186/s13034-023-00647-2.

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression.

Gen Psychiatr. 2023 Jun 21;36(3):e101007. doi: 10.1136/gpsych-2023-101007. eCollection 2023.

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression.

Front Psychiatry. 2023 Jun 2;14:1118737. doi: 10.3389/fpsyt.2023.1118737. eCollection 2023.

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.

Front Psychiatry. 2023 Mar 30;14:1141988. doi: 10.3389/fpsyt.2023.1141988. eCollection 2023.

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression.

Brain Sci. 2023 Jan 13;13(1):142. doi: 10.3390/brainsci13010142.

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.

BMC Psychiatry. 2022 Nov 30;22(1):744. doi: 10.1186/s12888-022-04388-y.

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression.

Front Behav Neurosci. 2022 Jun 21;16:938044. doi: 10.3389/fnbeh.2022.938044. eCollection 2022.